(Q77620488)
Statements
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha (English)
Mahon FX
Fabères C
Pueyo S
Cony-Makhoul P
Salmi R
Boiron JM
Marit G
Bilhou-Nabera C
Carrère A
Montastruc M
Pigneux A
Bernard P
1 December 1998